A multicentric prospective open trial on the quality of life and oxidative stress in patients affected by advanced head and neck cancer treated with a new benzoquinone-rich product derived from fermented wheat germ (Avemar)

Mediterranean Journal of Nutrition and Metabolism

Volumn 1, Issue 1, 2008, Pages 37-42

  Sukkar, Samir G ^a   Cella, Franca ^a   Rovera, Giuseppe M ^b   Nichelatti, Michele ^c   Ragni, Giuseppe ^a   Chiavenna, Giovanni ^d   Giannoni, Antonello ^e   Ronzani, Giovanni ^f   Ferrari, Claudia ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Ospedale Evangelico Valdese di Torino   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d A MANZONI HOSPITAL   (Italy)

^e Artificial Nutrition Unit   (Italy)

^f UOA Ortoped/Traumatol   (Italy)

Author keywords

D ROMs test; Fermented wheat germ extract; Head and neck cancer; Oxidative stress; Quality of life

Indexed keywords

EID: 85013605171     PISSN: 1973798X     EISSN: 19737998     Source Type: Journal    
DOI: 10.3233/s12349-008-0008-4     Document Type: Article

References (33)

1. Nelson K, Walsh D (1991). Management of the anorexia/cachexia syndrome. Cancer Bull, 43: 403-406.
2. Brennan MR (1997). Uncomplicated starvation vs cancer cachexia. Cancer Res, 37: 2359-2364.
3. Bruera E (1992) Clinical management of anorexia and cachexia in patients with advanced cancer. Oncology 49 [Suppl 2]: 35-42
4. Mantovani G, Macciò A, Massa E, Madeddu C (2001) Managing cancer-related anorexia/cachexia. Drugs 61(4): 499-514
5. Bruera E (1997). ABC of palliative care. Anorexia, cachexia and nutrition. BMJ, 315: 1219-1222.
6. Mantovani G, Madeddu C, Macciò A, Gramignano G et al (2004). Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. Cancer Epidemiol Biomarkers Prev, 13: 1651-1659.
7. Strassmann G, Fong M, Kenney JS, Jacob CO (1992). Evidence for the involvement of interleukin-6 in experimental cancer cachexia. J Clin Invest, 89: 1681-1684.
8. McLaughlin CL, Rogan GJ, Ton J (1992). Food intake and body temperature responses of rat to recombinant interleukin 1 beta and a tripeptide interleukin 1 beta antagonist. Physiol Behav, 52: 1155-1160.
9. Malmberg KJ, Lenkei R, Petersson M et al (2002). A short-term dietary supplementation of high doses of vitamin E increases T helper 1 cytokine production in patients with advanced colorectal cancer. Clin Cancer Res, 8: 1772-1778.
10. Bingisser RM, Tilbrook PA, Holt PG, Kees UR (1998). Macrophage-derived nitric oxide regulates T-cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol, 160: 5729-5734.
11. Weijl NI, Cleton FJ, Osanto S (1997). Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev, 23: 209-240.
12. Sabitha KE, Shyamaladevi CS (1999). Oxidant and antioxidant activity changes in patients with oral cancer and treated with chemotherapy. Oral Oncol, 35: 273-277.
13. Malmberg KJ, Lenkei R, Petersson M et al (2002). A short-term dietary supplementation of high doses of vitamin E increases T helper 1 cytokine production in patients with advanced colorectal cancer. Clin Cancer Res, 8: 1772-1778.
14. Illmer C, Madlener S, Horvath Z et al (2005). Immunologic and biochemical effects of the fermented wheat germ extract Avemar. Exp Biol Med, 230: 144-149.
15. Sukkar SG, Rossi E (2004). Oxidative stress and nutritional prevention in autoimmune rheumatic diseases. Autoimmun Rev, 3: 199-206.
16. Comìn-Anduix B, Boros LG, Marin S et al (2002). Fermented wheat germ extract inhibits glycolysis/pentose cycle enzymes and induces apoptosis through poly(ADP-ribose) polymerase activation in Jurkat T-cell leukemia tumour cells. J Biol Chem, 277: 46408-46414.
17. Fajka-Boja R, Hidvégi M, Shoenfeld Y et al (2002). Fermented wheat germ extract induces apoptosis and downregulation of major histocompatibility complex class I proteins in tumour T and B cell lines. Int J Oncol, 20: 563-570.
18. Gritz ER, Carmack CL, de Moor C et al (1999). First year after head and neck cancer: quality of life. J Clin Oncol, 17: 352-362.
19. Gritz ER, Hoffman A (1996) Behavioral and psychosocial issues in head and neck cancer. In: Beumer J, Curtis T, Marunick M (eds) Maxillofacial rehabilitation: prosthodontic and surgical considerations. Ishiyaku Euromica, St. Louis, pp 1-14
20. Gotay CC, Moore TD (1992). Assessing quality of life in head and neck cancer. Qual Life Res, 1: 5-17.
21. Bjordal K, Kaasa S (1995). Psychological distress in head and neck cancer patients 7-11 years after curative treatment. Br J Cancer, 71: 592-597.
22. Cornelli U, Terranova R, Luca S et al (2001). Bioavailability and antioxidant activity of some food supplements in men and women using the D-Roms test as a marker of oxidative stress. J Nutr, 131: 3208-3211.
23. Spitzer WO, Dobson AJ, Hall J (1981). Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis, 34: 585-597.
24. Michael M, Tannock IF (1998). Measuring health-related quality of life in clinical trials that evaluate the role of chemotherapy in cancer treatment. CMAJ, 158: 1727-1734.
25. Filiberti A (1990) Strumenti di validazione multidimensionale della qualità della vita. In: Tamburini M (ed) La valutazione della qualità della vita in oncologia. Masson, Milan
26. Sloan JA, Loprinzi CL, Kuross SA et al (1998). Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol, 16: 3662-3673.
27. Jakab F, Shoenfeld Y, Balogh A et al (2003). A medical nutriment has supportive value in the treatment of colorectal cancer. Br J Cancer, 89: 465-469.
28. Mantovani G, Maccio A, Madeddu C et al (2002). Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status. Int J Cancer, 98: 84-91.
29. Mantovani G, Maccio A, Madeddu C et al (2003). The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokine in a series of advanced cancer patients at different sites: correlation with disease progression. Free Radic Res, 37: 213-223.
30. Mantovani G, Maccio A, Melis G et al (2000). Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants α-lipoic acid and Nacetyl cysteine. Int J Cancer, 86: 842-847.
31. Capuron L, Dantzer R (2003) Cytokines and depression: the need for a new paradigm. Brain Behav Immun 17 [Suppl 1]:S119-S124
32. Fajka-Boja R, Hidvégi M, Shoenfeld Y et al (2001). Fermented wheat germ extract induces apoptosis and downregulation of major histocompatibility complex class I proteins in tumor T and B cell lines. Int J Oncol, 20: 563-570.
33. Griffioen AW, Damen CA, Martinotti S et al (1996). Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors. Cancer Res, 56: 1111-1117.